Challenging the standard of care in advanced melanoma: focus on pembrolizumab
Raghad M Abdul-Karim,1 C Lance Cowey2–4 1Baylor Sammons Cancer Center, 2Melanoma and Genitourinary Oncology Program, Baylor University Medical Center, Sammons Cancer Center Texas Oncology,3Baylor Skin Malignancy Research and Treatment Center, Baylor University Medical Center, 4Developmenta...
Main Authors: | Abdul-Karim RM, Cowey CL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/challenging-the-standard-of-care-in-advanced-melanoma-focus-on-pembrol-peer-reviewed-article-CMAR |
Similar Items
-
Pembrolizumab related Guillain barre syndrome, a rare presentation in a patient with a history of lupus and bladder cancer
by: Vikram Sangani, et al.
Published: (2021-05-01) -
Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy
by: Haque S, et al.
Published: (2017-08-01) -
Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the bone
by: Samuel Rosner, et al.
Published: (2017-04-01) -
New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab
by: Bylicki O, et al.
Published: (2018-07-01) -
Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma
by: Ester Simeone, et al.
Published: (2017-03-01)